Your browser doesn't support javascript.
loading
SENP1-Mediated HSP90ab1 DeSUMOylation in Cardiomyocytes Prevents Myocardial Fibrosis by Paracrine Signaling.
Liu, Zhihao; Bian, Xiyun; Li, Lan; Liu, Li; Feng, Chao; Wang, Ying; Ni, Jingyu; Li, Sheng; Lu, Dading; Li, Yanxia; Ma, Chuanrui; Yu, Tian; Xiao, Xiaolin; Xue, Na; Wang, Yuxiang; Zhang, Chunyan; Ma, Xiaofang; Gao, Xiumei; Fan, Xiaohui; Liu, Xiaozhi; Fan, Guanwei.
Afiliação
  • Liu Z; First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, 300193, China.
  • Bian X; State Key Laboratory of Component-Based Chinese Medicine, Tianjin, 301617, China.
  • Li L; Tianjin Key Laboratory of Epigenetics for Organ Development of Preterm Infants, Tianjin fifth Central Hospital, Tianjin, 300450, China.
  • Liu L; Central Laboratory, Tianjin Fifth Central Hospital, Tianjin, 300450, China.
  • Feng C; State Key Laboratory of Component-Based Chinese Medicine, Tianjin, 301617, China.
  • Wang Y; First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, 300193, China.
  • Ni J; State Key Laboratory of Component-Based Chinese Medicine, Tianjin, 301617, China.
  • Li S; Department of Cardiology, Tianjin Chest Hospital, Tianjin, 300051, China.
  • Lu D; Tianjin Key Laboratory of Epigenetics for Organ Development of Preterm Infants, Tianjin fifth Central Hospital, Tianjin, 300450, China.
  • Li Y; Central Laboratory, Tianjin Fifth Central Hospital, Tianjin, 300450, China.
  • Ma C; First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, 300193, China.
  • Yu T; State Key Laboratory of Component-Based Chinese Medicine, Tianjin, 301617, China.
  • Xiao X; Tianjin Key Laboratory of Epigenetics for Organ Development of Preterm Infants, Tianjin fifth Central Hospital, Tianjin, 300450, China.
  • Xue N; Central Laboratory, Tianjin Fifth Central Hospital, Tianjin, 300450, China.
  • Wang Y; Tianjin Key Laboratory of Epigenetics for Organ Development of Preterm Infants, Tianjin fifth Central Hospital, Tianjin, 300450, China.
  • Zhang C; Central Laboratory, Tianjin Fifth Central Hospital, Tianjin, 300450, China.
  • Ma X; First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, 300193, China.
  • Gao X; Tianjin Key Laboratory of Epigenetics for Organ Development of Preterm Infants, Tianjin fifth Central Hospital, Tianjin, 300450, China.
  • Fan X; Central Laboratory, Tianjin Fifth Central Hospital, Tianjin, 300450, China.
  • Liu X; Tianjin Key Laboratory of Epigenetics for Organ Development of Preterm Infants, Tianjin fifth Central Hospital, Tianjin, 300450, China.
  • Fan G; Central Laboratory, Tianjin Fifth Central Hospital, Tianjin, 300450, China.
Adv Sci (Weinh) ; : e2400741, 2024 Jul 11.
Article em En | MEDLINE | ID: mdl-38992961
ABSTRACT
Myocardial infarction (MI) triggers a poor ventricular remodeling response, but the underlying mechanisms remain unclear. Here, the authors show that sentrin-specific protease 1 (SENP1) is downregulated in post-MI mice and in patients with severe heart failure. By generating cardiomyocyte-specific SENP1 knockout and overexpression mice to assess cardiac function and ventricular remodeling responses under physiological and pathological conditions. Increased cardiac fibrosis in the cardiomyocyte-specific SENP1 deletion mice, associated with increased fibronectin (Fn) expression and secretion in cardiomyocytes, promotes fibroblast activation in response to myocardial injury. Mechanistically, SENP1 deletion in mouse cardiomyocytes increases heat shock protein 90 alpha family class B member 1 (HSP90ab1) SUMOylation with (STAT3) activation and Fn secretion after ventricular remodeling initiated. Overexpression of SENP1 or mutation of the HSP90ab1 Lys72 ameliorates adverse ventricular remodeling and dysfunction after MI. Taken together, this study identifies SENP1 as a positive regulator of cardiac repair and a potential drug target for the treatment of MI. Inhibition of HSP90ab1 SUMOylation stabilizes STAT3 to inhibit the adverse ventricular remodeling response.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Adv Sci (Weinh) Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Adv Sci (Weinh) Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China